ONTOZRY® is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled, despite treatment with at least 2 anti-epileptic medicinal products.1
Read about and listen to conversations from the Ontozry® Live Forum which was co-chaired by globally respected epilepsy specialists Prof Ley Sander, Dr Rhys Thomas and Phil Tittensor
1. ONTOZRY® Summary of product characteristics. 2. Krauss GL, et al. Lancet Neurol. 2020;19(1):38-48.
P-UK-CE-2100008 | December 2021